Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 22.55 HKD -5.85% Market Closed
Market Cap: 875.7m HKD
Have any thoughts about
Shanghai HeartCare Medical Technology Corp Ltd?
Write Note

Shanghai HeartCare Medical Technology Corp Ltd
Investor Relations

Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Guohui Wang
Chairman & CEO
No Bio Available
Mr. Jiawei Wei
Deputy GM & Executive Director
No Bio Available
Mr. Han Zhang
CFO & Joint Company Secretary
No Bio Available
Mr. Zongyu Xue
VP of Quality Regulation & Employee Representative Supervisor
No Bio Available
Ms. Siu Ying Kwok
Joint Company Secretary
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
2/F, Building 9 South, 590 Ruiqing Avenue, Zhangjiang High Technology Park East
Contacts